“…Physiological and hormonal changes occur during pregnancy, which affects lipid metabolism and, therefore, the composition of FAs in target tissues [ 15 , 16 ]. The detection of FA in erythrocyte membrane phospholipids, as a potential biomarker, can reflect the risk of complications during pregnancy [ 17 , 18 ]. The FA composition of erythrocyte membrane phospholipids depends on the dietary intake of various FAs as well as age, ethnicity, genetics and endogenous metabolism, body mass index, health status including liver metabolism, lifestyle factors—smoking, alcohol consumption, physical activity—among other factors [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ].…”